Celiac Disease (Gluten-Sensitive Enteropathy)
Autoimmune Small Intestine Malabsorptive Enteropathy
Primary risk age: Infants transitioning to solid foods (typically 9 to 24 months) through adolescence.
- Urgency
- Moderate
- Typical age
- Infants transitioning to solid foods (typically 9 to 24 months) through adolescence.
- Body system
- Gastrointestinal System
Typical course: Clinical improvement is often seen within weeks; full histological normalization of the intestinal villi takes 6 to 12 months.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Autoimmune Small Intestine Malabsorptive Enteropathy
Pathophysiology (Development Path)
Ingested gluten is broken down into gliadin peptides, which are deamidated by the enzyme tissue transglutaminase (tTG). In genetically predisposed children, these deamidated peptides are recognized as foreign by T-helper cells. This triggers an inflammatory response that causes crypt hyperplasia and progressive villous atrophy, blunting the lining of the small intestine and leading to widespread malabsorption.
Primary Causes & Etiology
Dietary exposure to gluten proteins found in wheat, rye, and barley, triggering an autoimmune response in individuals with HLA-DQ2 or HLA-DQ8 genetic markers.
2. Symptom Continuum
- Early Onset Signs
Intermittent abdominal bloating, mild diarrhea, decreased appetite, and irritability following the introduction of gluten-containing cereals.
- Progressive Phase
Sustained steatorrhea (pale, bulky, foul-smelling stools), progressive weight loss or failure to thrive, muscle wasting in the limbs, and recurrent abdominal pain.
- Severe Indicators
Anorexia, severe malnutrition, short stature, delayed puberty, aphthous stomatitis, iron-deficiency anemia resistant to oral supplements, and a "celiac crisis" characterized by explosive diarrhea and hypokalemia.
3. Clinical Verification
Serological screening for Elevated IgA anti-Tissue Transglutaminase (tTG) antibodies. Diagnosis is confirmed with an upper endoscopy and duodenal biopsy showing characteristic villous blunting.
4. Care & Elements Plan
Primary Care Treatment Plan
Strict, lifelong elimination of dietary gluten. This resolves intestinal inflammation, restores normal mucosal structure, and supports catch-up growth.
Home Support Elements
Maintain a strict gluten-free home environment. Carefully screen food labels and avoid cross-contamination in kitchen preparation areas.
Generic Active Ingredients (No Brands)
- Iron amino acid chelate (for secondary anemia support)
- Cholecalciferol (Vitamin D3) and Calcium supplementation if bone density indicators are low. No primary pharmaceutical cures exist.
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Consult a pediatrician if a child experiences chronic diarrhea, persistent abdominal distension, unexplained weight loss, or delayed growth milestones.
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
No definitive preventative measures exist. Introducing gluten while continuing breastfeeding does not prevent the condition but may alter its early presentation.
Immunization Context
No specific immunizations are linked to this metabolic disorder. Pneumococcal vaccination is recommended due to potential functional hyposplenism in long-standing untreated cases.
7. Timelines & Outlook
Active Timeline
Clinical improvement is often seen within weeks; full histological normalization of the intestinal villi takes 6 to 12 months.
Expected Prognosis
Excellent with complete adherence to a gluten-free diet. Intestinal mucosa healing typically occurs within several months, allowing for normal growth and development.
Potential Untreated Complications
Refractory growth failure, osteopenia, iron-deficiency anemia, dermatitis herpetiformis, and an increased long-term risk of intestinal lymphoma if dietary non-compliance persists.
More in Chronic Autoimmune & Structural Gastrointestinal Disorders
Severe Hirschsprung Disease (Congenital Megacolon)
Congenital Intestinal Aganglionosis Motor Obstruction
Neonates (Typically diagnosed in the first few days of life; occasionally in older infants)
Moderate Pediatric Inguinal Hernia
Congenital Structural Inguinal Defect
Infancy to Childhood (More common in males and premature infants)
Mild Functional Constipation
Common functional disorder of infrequent or painful, hard bowel movements without an underlying disease.
All ages; peaks at toilet training, starting solids, and school entry.